Skip to main content
Fig. 1 | BMC Immunology

Fig. 1

From: Detecting the preoperative peripheral blood systemic immune-inflammation index (SII) as a tool for early diagnosis and prognosis of gallbladder cancer

Fig. 1

Preoperative SII and tumor marker expression levels (CEA, CA125, and CA19-9) in GBC patients and their correlations. The differences in preoperative SII (A), CEA (B), CA125 (C), and CA19-9 (D) expression levels between 90 patients with benign gallbladder lesions and the GBC group were analyzed and compared. Data that conformed to the normal distribution of measures were compared between the two groups using the independent sample t-test, and data that did not conform to the normal distribution of measures were compared using the Mann-Whitney U test. *** P < 0.001. Spearman was used to analyze the correlations of preoperative SII with serum biomarkers CEA (E), CA125 (F), and CA19-9 (G) levels in GBC patients

Back to article page